Company intelligence / Profile preview

Grinta

Cairo, Cairo Governorate, Egyptgrinta.ai ↗

Ownership: Private
Development stage: Other

Overview

Grinta operates a fintech-enabled B2B digital platform that modernizes the pharmaceutical supply chain in Africa. It connects independent pharmacies with manufacturers, distributors, and wholesalers to provide access to traceable pharmaceuticals and medical products. The company offers fulfillment services, demand planning tools, inventory financing solutions, and recently expanded into direct patient care through acquisitions such as Citi Clinic. As of 2025, it serves thousands of pharmacies across Egypt and Tanzania.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Works with manufacturers, distributors, wholesalers across the pharma value chain

Beyond the preview

Go deeper on Grinta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grinta.

Explore the full profile